GENESIS MEDTECH ACQUIRES WORLD-FIRST DRUG-COATED BALLOON TECHNOLOGY WITH NEXT-GENERATION ANGIOPLASTY ARCHITECTURE FOR THE TREATMENT OF PERIPHERAL VASCULAR DISEASES
SINGAPORE, August 29, 2020 – Genesis MedTech International has completed the acquisition of the Chocolate Touch ® drug-coated balloon (DCB), a drug-device technology asset from TriReme Medical LLC, a wholly-owned subsidiary of Singapore-listed QT Vascular Ltd